KYTX · Kyverna Therapeutics, Inc. · Webcasts, Transcripts & Audio
$5.84
-0.20 (-3.31%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$373.53M
Shares
61.84M
Volume · Oct 21
829.53K
Avg daily vol (3M)
832.78K
Kyverna Therapeutics, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Kyverna Therapeutics, Inc. (KYTX), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-09-24
Kyverna Therapeutics, Inc. (KYTX) September 24, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-15
Kyverna Therapeutics, Inc. (KYTX) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-14
Kyverna Therapeutics, Inc. (KYTX) September 14, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-09
Kyverna Therapeutics, Inc. (KYTX) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Kyverna Therapeutics, Inc. (KYTX) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-22
Kyverna Therapeutics, Inc. (KYTX) Q1 2026 Earnings Call
Diluted EPS
$-0.66
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-04-22
Kyverna Therapeutics, Inc. (KYTX) April 22, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-01-12
Kyverna Therapeutics, Inc. (KYTX) Q4 2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-29
Kyverna Therapeutics, Inc. (KYTX) Q3 2025 Earnings Call
Diluted EPS
$-0.85
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-28
Kyverna Therapeutics, Inc. (KYTX) Q2 2025 Earnings Call
Diluted EPS
$-0.97
Audio
Transcript
Slides
8-K10-Q
Showing 1–10 of 10 webcasts